source
- J&J restructures pharma supply chain, offloading sites as part of $55 B U.S. manufacturing pushJohnson & Johnson announced it is restructuring its pharmaceutical supply chain, offloading certain sites to streamline operations as part of its $55 billion U.S. manufacturing initiative. The cha…
- FDA acting chief says two journal articles by former commissioner do not represent agency policyActing FDA Commissioner Kyle Diamantas announced that the agency is reversing its earlier position regarding two medical‑journal articles authored by former commissioner Marty Makary. The FDA now…